Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Denali Therapeutics (DNLI) Debt to Equity (2022)

Denali Therapeutics has reported Debt to Equity over the past 1 years, most recently at $0.0 for Q4 2022.

  • Quarterly Debt to Equity changed N/A to $0.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $0.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $0.0 for FY2022, N/A changed from the prior year.
  • Debt to Equity was $0.0 for Q4 2022 at Denali Therapeutics, up from $0.0 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.0 in Q4 2022 and troughed at $0.0 in Q3 2022.